| HERON THERAPEUTICS DL-,01 |
| USA |
| Gesundheit |
| US4277461020 / A1XB6K |
| AXD2 (Frankfurt) / HRTX (NASDAQ) |
| FRA:AXD2, ETR:AXD2, AXD2:GR, NASDAQ:HRTX |
| - |
| https://www.herontx.com/ |
|
Heron Therapeutics Inc. is a biotechnology company..
>Volltext.. |
| 206.2 Mio. EUR |
| 285.21 Mio. EUR |
| 133.14 Mio. EUR |
| 3.82 Mio. EUR |
| -11.66 Mio. EUR |
| -0.07 EUR |
| 120.56 Mio. EUR |
| 36.97 Mio. EUR |
| -25.91 Mio. EUR |
| 0.62 |
| 6.84% |
| 53.93% |
| - |
| - |
| - |
| - |
| HERON THERAPEUTICS, HERON THERAPEUTIC |
| 09.12.25 |
|